CRLBF
Price
$1.05
Change
-$0.15 (-12.50%)
Updated
Sep 25 closing price
Capitalization
377.65M
42 days until earnings call
JUSHF
Price
$0.61
Change
-$0.10 (-14.08%)
Updated
Sep 25 closing price
Capitalization
120.8M
53 days until earnings call
Interact to see
Advertisement

CRLBF vs JUSHF

Header iconCRLBF vs JUSHF Comparison
Open Charts CRLBF vs JUSHFBanner chart's image
Cresco Labs
Price$1.05
Change-$0.15 (-12.50%)
Volume$795.62K
Capitalization377.65M
Jushi Holdings
Price$0.61
Change-$0.10 (-14.08%)
Volume$260.79K
Capitalization120.8M
CRLBF vs JUSHF Comparison Chart in %
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. JUSHF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and JUSHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CRLBF: $1.05 vs. JUSHF: $0.61)
Brand notoriety: CRLBF and JUSHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRLBF: 47% vs. JUSHF: 34%
Market capitalization -- CRLBF: $377.65M vs. JUSHF: $120.8M
CRLBF [@Pharmaceuticals: Generic] is valued at $377.65M. JUSHF’s [@Pharmaceuticals: Generic] market capitalization is $120.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileJUSHF’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • JUSHF’s FA Score: 0 green, 5 red.
According to our system of comparison, JUSHF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 5 TA indicator(s) are bullish while JUSHF’s TA Score has 3 bullish TA indicator(s).

  • CRLBF’s TA Score: 5 bullish, 3 bearish.
  • JUSHF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CRLBF is a better buy in the short-term than JUSHF.

Price Growth

CRLBF (@Pharmaceuticals: Generic) experienced а -0.94% price change this week, while JUSHF (@Pharmaceuticals: Generic) price change was -11.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

CRLBF is expected to report earnings on Nov 07, 2025.

JUSHF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($378M) has a higher market cap than JUSHF($121M). JUSHF YTD gains are higher at: 96.495 vs. CRLBF (14.914). CRLBF has higher annual earnings (EBITDA): 136M vs. JUSHF (44.8M). CRLBF has more cash in the bank: 147M vs. JUSHF (23.2M). JUSHF has less debt than CRLBF: JUSHF (269M) vs CRLBF (631M). CRLBF has higher revenues than JUSHF: CRLBF (685M) vs JUSHF (256M).
CRLBFJUSHFCRLBF / JUSHF
Capitalization378M121M312%
EBITDA136M44.8M304%
Gain YTD14.91496.49515%
P/E RatioN/AN/A-
Revenue685M256M268%
Total Cash147M23.2M634%
Total Debt631M269M235%
FUNDAMENTALS RATINGS
CRLBF vs JUSHF: Fundamental Ratings
CRLBF
JUSHF
OUTLOOK RATING
1..100
7581
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
3936
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JUSHF's Valuation (49) in the null industry is in the same range as CRLBF (78). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

JUSHF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

CRLBF's SMR Rating (94) in the null industry is in the same range as JUSHF (100). This means that CRLBF’s stock grew similarly to JUSHF’s over the last 12 months.

JUSHF's Price Growth Rating (36) in the null industry is in the same range as CRLBF (39). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

JUSHF's P/E Growth Rating (100) in the null industry is in the same range as CRLBF (100). This means that JUSHF’s stock grew similarly to CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFJUSHF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLNPX46.12N/A
N/A
Voya Small Cap Growth R6
ECEAX35.52N/A
N/A
Eaton Vance Tax-Managed Eq Aset Allc C
OTCNX83.01N/A
N/A
Invesco Discovery Large Cap R
IPESX5.36N/A
N/A
Voya Large Cap Value Port S
VESAX19.51N/A
N/A
VELA Small Cap A

CRLBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-12.50%
TSNDF - CRLBF
76%
Closely correlated
-12.47%
CURLF - CRLBF
76%
Closely correlated
-6.87%
TCNNF - CRLBF
75%
Closely correlated
-7.20%
JUSHF - CRLBF
74%
Closely correlated
-13.74%
VRNOF - CRLBF
73%
Closely correlated
-7.20%
More

JUSHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JUSHF has been closely correlated with TCNNF. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if JUSHF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JUSHF
1D Price
Change %
JUSHF100%
-13.74%
TCNNF - JUSHF
74%
Closely correlated
-7.20%
CRLBF - JUSHF
74%
Closely correlated
-12.50%
CURLF - JUSHF
72%
Closely correlated
-6.87%
TSNDF - JUSHF
71%
Closely correlated
-12.47%
GTBIF - JUSHF
70%
Closely correlated
-7.42%
More